Anixa Biosciences Inc. ( ANIX ) shares surged 15.21% in after-hours trading on Thursday, reaching $5.53, after the company presented final Phase 1 clinical trial data for its investigational breast cancer vaccine.

Check out the current price of ANIX stock here.

Phase 1 Trial Results

The healthcare company presented final data Thursday at the 2025 San Antonio Breast Cancer Symposium. The trial, conducted with the Cleveland Clinic and funded by a U.S. Department of Defense grant, showed the vaccine met all major primary endpoints.

Protocol-defined immune responses occurred in 74% of participants.

Dr. G. Thomas Budd, principal investigator at the Cleveland Clinic, said, “The investigational α-lactalbumin vaccine was safe and well tolerated at the maximum tolerated dose and generated protocol-defined immune responses in 74% of participants—results that support continued clinical evaluation.”

See Also: Why Are cbdMD (YCBD) Shares Surging 55% After Hours?

The California-based company stated that final Phase 1 findings showed the vaccine was safe and well-tolerated at the maximum tolerated dose.

The trial enrolled 35 participants across three cohorts.

Next Steps

Anixa Biosciences ( ANIX ) noted that the trial data will inform a planned Phase 2 study design, including a potential combination trial with Keytruda in the neoadjuvant setting for newly diagnosed breast cancer patients.

Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences ( ANIX ), stated, “We look forward to engaging with regulators and advancing plans for a Phase 2 study.”

Trading Metrics

The stock of the clinical-stage biotech has gained 106.90% year to date.

Anixa Biosciences ( ANIX ) has a market capitalization of $158 million, with a 52-week range of $2.07 to $5.46.

Price Action: According to Benzinga Pro data, ANIX closed on Thursday at $4.80, down 6.43%.

Benzinga’s Edge Stock Rankings indicates ANIX stock has a positive price trend across all time frames.  Track the performance of other players in this segment.

Read Next:

Why Are Luminar Technologies (LAZR) Shares Trending?

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.